Company / Gross Profit per Share
Gilead Sciences Gross Profit per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$3.31
FY2019
5-year range
-
FY2016-FY2019
Trend
+8.2%
vs FY2018
Sector context
#20 of 29
Health Care
What the data says
At $3.31, Gilead Sciences's gross profit per share ranks #20 of 29 in the Health Care sector. Gross Profit per Share returned to growth in FY2019 after 2 years of decline, reaching $3.31.
Based on SEC 10-K filings.
3.31 in FY2019 with a 3-year CAGR of -10.1%.
Declined from $4.14 to $3.31 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#20 of 29 in Health CareTop 69% of 29This company $3.31 Sector average $8.10
▼
-59.2% below sector average
Key checks
Key Insights
- In FY2019, gross profit per share increased 8.2% year-over-year.
- Ranks #20 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $3.31 | +8.2% |
| FY2018 | $3.06 | -26.1% |
| FY2017 | $4.14 | -9.3% |
| FY2016 | $4.56 | +4.8% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026